These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33358985)

  • 21. Convergent evidence for mGluR5 in synaptic and neuroinflammatory pathways implicated in ASD.
    Zantomio D; Chana G; Laskaris L; Testa R; Everall I; Pantelis C; Skafidas E
    Neurosci Biobehav Rev; 2015 May; 52():172-7. PubMed ID: 25704074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired neurodevelopmental pathways in autism spectrum disorder: a review of signaling mechanisms and crosstalk.
    Kumar S; Reynolds K; Ji Y; Gu R; Rai S; Zhou CJ
    J Neurodev Disord; 2019 Jun; 11(1):10. PubMed ID: 31202261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabidiol as a suggested candidate for treatment of autism spectrum disorder.
    Poleg S; Golubchik P; Offen D; Weizman A
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():90-96. PubMed ID: 30171992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma anandamide concentrations are lower in children with autism spectrum disorder.
    Karhson DS; Krasinska KM; Dallaire JA; Libove RA; Phillips JM; Chien AS; Garner JP; Hardan AY; Parker KJ
    Mol Autism; 2018; 9():18. PubMed ID: 29564080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocannabinoid System Unlocks the Puzzle of Autism Treatment
    Su T; Yan Y; Li Q; Ye J; Pei L
    Front Psychiatry; 2021; 12():734837. PubMed ID: 34744824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary Phytochemicals as Neurotherapeutics for Autism Spectrum Disorder: Plausible Mechanism and Evidence.
    Bhandari R; Paliwal JK; Kuhad A
    Adv Neurobiol; 2020; 24():615-646. PubMed ID: 32006377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autism Spectrum Disorder: Signaling Pathways and Prospective Therapeutic Targets.
    Baranova J; Dragunas G; Botellho MCS; Ayub ALP; Bueno-Alves R; Alencar RR; Papaiz DD; Sogayar MC; Ulrich H; Correa RG
    Cell Mol Neurobiol; 2021 May; 41(4):619-649. PubMed ID: 32468442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autism and associated disorders: cannabis as a potential therapy.
    Babayeva M; Assefa H; Basu P; Loewy Z
    Front Biosci (Elite Ed); 2022 Jan; 14(1):1. PubMed ID: 35320905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environmental influence on neurodevelopmental disorders: Potential association of heavy metal exposure and autism.
    Ijomone OM; Olung NF; Akingbade GT; Okoh COA; Aschner M
    J Trace Elem Med Biol; 2020 Dec; 62():126638. PubMed ID: 32891009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD).
    Hughes HK; R J Moreno ; Ashwood P
    Brain Behav Immun; 2023 Feb; 108():245-254. PubMed ID: 36494048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
    Prem S; Millonig JH; DiCicco-Bloom E
    Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antineuroinflammatory therapy: potential treatment for autism spectrum disorder by inhibiting glial activation and restoring synaptic function.
    Li YJ; Zhang X; Li YM
    CNS Spectr; 2020 Aug; 25(4):493-501. PubMed ID: 31659946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Autism-Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System.
    Colizzi M; Bortoletto R; Costa R; Bhattacharyya S; Balestrieri M
    Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35565034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A potential mechanistic role for neuroinflammation in reward processing impairments in autism spectrum disorder.
    Greene RK; Walsh E; Mosner MG; Dichter GS
    Biol Psychol; 2019 Mar; 142():1-12. PubMed ID: 30552950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysregulation of Multiple Signaling Neurodevelopmental Pathways during Embryogenesis: A Possible Cause of Autism Spectrum Disorder.
    Upadhyay J; Patra J; Tiwari N; Salankar N; Ansari MN; Ahmad W
    Cells; 2021 Apr; 10(4):. PubMed ID: 33924211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective study of fetal head growth, autistic traits and autism spectrum disorder.
    Blanken LME; Dass A; Alvares G; van der Ende J; Schoemaker NK; El Marroun H; Hickey M; Pennell C; White S; Maybery MT; Dissanayake C; Jaddoe VWV; Verhulst FC; Tiemeier H; McIntosh W; White T; Whitehouse A
    Autism Res; 2018 Apr; 11(4):602-612. PubMed ID: 29356450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Association Between Somatic Health, Autism Spectrum Disorder, and Autistic Traits.
    Pan PY; Tammimies K; Bölte S
    Behav Genet; 2020 Jul; 50(4):233-246. PubMed ID: 31811521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of Protein Synthesis: An Approach to Treat Autism Spectrum Disorder (ASD).
    Teixeira JP; Ramalho TC
    Curr Med Chem; 2021 Oct; 28(34):7141-7156. PubMed ID: 33874864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear Peroxisome Proliferator-Activated Receptors (PPARs) as Therapeutic Targets of Resveratrol for Autism Spectrum Disorder.
    Barone R; Rizzo R; Tabbì G; Malaguarnera M; Frye RE; Bastin J
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30995737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid-Based Molecules on Signaling Pathways in Autism Spectrum Disorder.
    Yui K; Imataka G; Yoshihara S
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.